tryptophan has been researched along with Neuroleptic Malignant Syndrome in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (33.33) | 18.7374 |
| 1990's | 2 (66.67) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Sternbach, H | 1 |
| Meltzer, HY; Parsa, MA; Ramirez, LF; Rohr, T | 1 |
| Kline, SS; Mauro, LS; Scala-Barnett, DM; Zick, D | 1 |
1 review(s) available for tryptophan and Neuroleptic Malignant Syndrome
| Article | Year |
|---|---|
The serotonin syndrome.
Topics: Adult; Antidepressive Agents; Basal Ganglia Diseases; Depressive Disorder; Drug Interactions; Drug Therapy, Combination; Dyskinesia, Drug-Induced; Female; Fluoxetine; Humans; Male; Monoamine Oxidase Inhibitors; Neuroleptic Malignant Syndrome; Receptors, Serotonin; Serotonin; Tryptophan | 1991 |
2 other study(ies) available for tryptophan and Neuroleptic Malignant Syndrome
| Article | Year |
|---|---|
Neuroleptic malignant syndrome without neuroleptics.
Topics: Aged; Aged, 80 and over; Antiparkinson Agents; Carbidopa; Depressive Disorder; Drug Combinations; Drug Therapy, Combination; Female; Humans; Levodopa; Neuroleptic Malignant Syndrome; Parkinson Disease; Substance Withdrawal Syndrome; Tranylcypromine; Tryptophan | 1990 |
Serotonin syndrome versus neuroleptic malignant syndrome as a cause of death.
Topics: Antidepressive Agents, Tricyclic; Antipsychotic Agents; Cause of Death; Creatine Kinase; Depressive Disorder; Drug Therapy, Combination; Female; Fever; Humans; Middle Aged; Monoamine Oxidase Inhibitors; Neuroleptic Malignant Syndrome; Seizures; Serotonin; Syndrome; Tryptophan | 1989 |